Overview of drug markets in the European Neighbourhood Policy-South countries


This report presents an analysis of the drug markets in the European Neighbourhood Policy-South region covering Algeria, Egypt, Israel, Jordan, Lebanon, Libya, Morocco, Palestine (*), Syria and Tunisia. Focused on providing insights into drug production, trafficking, sale, use and harms, the report contains data and information from a review of publicly available information and selected studies conducted between 2019 and 2022 in the framework of the EU4Monitoring Drugs project, funded by the European Commission. It concludes with an outlook on key areas for policy and practice to address emerging drug market challenges.


(*) This designation shall not be construed as recognition of a State of Palestine and is without prejudice to the individual positions of the Member States on this issue.

Table of contents

  • Acknowledgements
  • Introduction
  • Key findings
  • Main drivers and facilitators of drug markets
  • Cannabis
  • Captagon and other amphetamines
  • Cocaine
  • Heroin and other opioids
  • MDMA
  • New psychoactive substances
  • Diverted pharmaceuticals
  • Outlook
  • Abbreviations
  • References